Cellular Tumor Antigen p53 Market
1 Study Coverage
1.1 Cellular Tumor Antigen p53 Product Introduction
1.2 Market by Type
1.2.1 Global Cellular Tumor Antigen p53 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 COTI-2
1.2.3 D-12PGJ3
1.2.4 APR-246
1.2.5 ATRN-502
1.2.6 Cenersen Sodium
1.2.7 MJ-05
1.2.8 MX-225
1.2.9 Others
1.3 Market by Application
1.3.1 Global Cellular Tumor Antigen p53 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Ovarian Cancer
1.3.3 Prostate Cancer
1.3.4 Brain Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cellular Tumor Antigen p53 Sales Estimates and Forecasts 2017-2028
2.2 Global Cellular Tumor Antigen p53 Revenue Estimates and Forecasts 2017-2028
2.3 Global Cellular Tumor Antigen p53 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cellular Tumor Antigen p53 Sales by Region
2.4.1 Global Cellular Tumor Antigen p53 Sales by Region (2017-2022)
2.4.2 Global Sales Cellular Tumor Antigen p53 by Region (2023-2028)
2.5 Global Cellular Tumor Antigen p53 Revenue by Region
2.5.1 Global Cellular Tumor Antigen p53 Revenue by Region (2017-2022)
2.5.2 Global Cellular Tumor Antigen p53 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cellular Tumor Antigen p53 Sales by Manufacturers
3.1.1 Global Top Cellular Tumor Antigen p53 Manufacturers by Sales (2017-2022)
3.1.2 Global Cellular Tumor Antigen p53 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cellular Tumor Antigen p53 in 2021
3.2 Global Cellular Tumor Antigen p53 Revenue by Manufacturers
3.2.1 Global Cellular Tumor Antigen p53 Revenue by Manufacturers (2017-2022)
3.2.2 Global Cellular Tumor Antigen p53 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cellular Tumor Antigen p53 Revenue in 2021
3.3 Global Cellular Tumor Antigen p53 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cellular Tumor Antigen p53 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cellular Tumor Antigen p53 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cellular Tumor Antigen p53 Sales by Type
4.1.1 Global Cellular Tumor Antigen p53 Historical Sales by Type (2017-2022)
4.1.2 Global Cellular Tumor Antigen p53 Forecasted Sales by Type (2023-2028)
4.1.3 Global Cellular Tumor Antigen p53 Sales Market Share by Type (2017-2028)
4.2 Global Cellular Tumor Antigen p53 Revenue by Type
4.2.1 Global Cellular Tumor Antigen p53 Historical Revenue by Type (2017-2022)
4.2.2 Global Cellular Tumor Antigen p53 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cellular Tumor Antigen p53 Revenue Market Share by Type (2017-2028)
4.3 Global Cellular Tumor Antigen p53 Price by Type
4.3.1 Global Cellular Tumor Antigen p53 Price by Type (2017-2022)
4.3.2 Global Cellular Tumor Antigen p53 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cellular Tumor Antigen p53 Sales by Application
5.1.1 Global Cellular Tumor Antigen p53 Historical Sales by Application (2017-2022)
5.1.2 Global Cellular Tumor Antigen p53 Forecasted Sales by Application (2023-2028)
5.1.3 Global Cellular Tumor Antigen p53 Sales Market Share by Application (2017-2028)
5.2 Global Cellular Tumor Antigen p53 Revenue by Application
5.2.1 Global Cellular Tumor Antigen p53 Historical Revenue by Application (2017-2022)
5.2.2 Global Cellular Tumor Antigen p53 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cellular Tumor Antigen p53 Revenue Market Share by Application (2017-2028)
5.3 Global Cellular Tumor Antigen p53 Price by Application
5.3.1 Global Cellular Tumor Antigen p53 Price by Application (2017-2022)
5.3.2 Global Cellular Tumor Antigen p53 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cellular Tumor Antigen p53 Market Size by Type
6.1.1 North America Cellular Tumor Antigen p53 Sales by Type (2017-2028)
6.1.2 North America Cellular Tumor Antigen p53 Revenue by Type (2017-2028)
6.2 North America Cellular Tumor Antigen p53 Market Size by Application
6.2.1 North America Cellular Tumor Antigen p53 Sales by Application (2017-2028)
6.2.2 North America Cellular Tumor Antigen p53 Revenue by Application (2017-2028)
6.3 North America Cellular Tumor Antigen p53 Market Size by Country
6.3.1 North America Cellular Tumor Antigen p53 Sales by Country (2017-2028)
6.3.2 North America Cellular Tumor Antigen p53 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Cellular Tumor Antigen p53 Market Size by Type
7.1.1 Europe Cellular Tumor Antigen p53 Sales by Type (2017-2028)
7.1.2 Europe Cellular Tumor Antigen p53 Revenue by Type (2017-2028)
7.2 Europe Cellular Tumor Antigen p53 Market Size by Application
7.2.1 Europe Cellular Tumor Antigen p53 Sales by Application (2017-2028)
7.2.2 Europe Cellular Tumor Antigen p53 Revenue by Application (2017-2028)
7.3 Europe Cellular Tumor Antigen p53 Market Size by Country
7.3.1 Europe Cellular Tumor Antigen p53 Sales by Country (2017-2028)
7.3.2 Europe Cellular Tumor Antigen p53 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cellular Tumor Antigen p53 Market Size by Type
8.1.1 Asia Pacific Cellular Tumor Antigen p53 Sales by Type (2017-2028)
8.1.2 Asia Pacific Cellular Tumor Antigen p53 Revenue by Type (2017-2028)
8.2 Asia Pacific Cellular Tumor Antigen p53 Market Size by Application
8.2.1 Asia Pacific Cellular Tumor Antigen p53 Sales by Application (2017-2028)
8.2.2 Asia Pacific Cellular Tumor Antigen p53 Revenue by Application (2017-2028)
8.3 Asia Pacific Cellular Tumor Antigen p53 Market Size by Region
8.3.1 Asia Pacific Cellular Tumor Antigen p53 Sales by Region (2017-2028)
8.3.2 Asia Pacific Cellular Tumor Antigen p53 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Cellular Tumor Antigen p53 Market Size by Type
9.1.1 Latin America Cellular Tumor Antigen p53 Sales by Type (2017-2028)
9.1.2 Latin America Cellular Tumor Antigen p53 Revenue by Type (2017-2028)
9.2 Latin America Cellular Tumor Antigen p53 Market Size by Application
9.2.1 Latin America Cellular Tumor Antigen p53 Sales by Application (2017-2028)
9.2.2 Latin America Cellular Tumor Antigen p53 Revenue by Application (2017-2028)
9.3 Latin America Cellular Tumor Antigen p53 Market Size by Country
9.3.1 Latin America Cellular Tumor Antigen p53 Sales by Country (2017-2028)
9.3.2 Latin America Cellular Tumor Antigen p53 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cellular Tumor Antigen p53 Market Size by Type
10.1.1 Middle East and Africa Cellular Tumor Antigen p53 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cellular Tumor Antigen p53 Revenue by Type (2017-2028)
10.2 Middle East and Africa Cellular Tumor Antigen p53 Market Size by Application
10.2.1 Middle East and Africa Cellular Tumor Antigen p53 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cellular Tumor Antigen p53 Revenue by Application (2017-2028)
10.3 Middle East and Africa Cellular Tumor Antigen p53 Market Size by Country
10.3.1 Middle East and Africa Cellular Tumor Antigen p53 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cellular Tumor Antigen p53 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Advaxis, Inc.
11.1.1 Advaxis, Inc. Corporation Information
11.1.2 Advaxis, Inc. Overview
11.1.3 Advaxis, Inc. Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Advaxis, Inc. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Advaxis, Inc. Recent Developments
11.2 American Gene Technologies International Inc.
11.2.1 American Gene Technologies International Inc. Corporation Information
11.2.2 American Gene Technologies International Inc. Overview
11.2.3 American Gene Technologies International Inc. Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 American Gene Technologies International Inc. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 American Gene Technologies International Inc. Recent Developments
11.3 Aprea AB
11.3.1 Aprea AB Corporation Information
11.3.2 Aprea AB Overview
11.3.3 Aprea AB Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Aprea AB Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Aprea AB Recent Developments
11.4 Cellceutix Corporation
11.4.1 Cellceutix Corporation Corporation Information
11.4.2 Cellceutix Corporation Overview
11.4.3 Cellceutix Corporation Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cellceutix Corporation Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cellceutix Corporation Recent Developments
11.5 Critical Outcome Technologies Inc.
11.5.1 Critical Outcome Technologies Inc. Corporation Information
11.5.2 Critical Outcome Technologies Inc. Overview
11.5.3 Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Critical Outcome Technologies Inc. Recent Developments
11.6 Eleos Inc.
11.6.1 Eleos Inc. Corporation Information
11.6.2 Eleos Inc. Overview
11.6.3 Eleos Inc. Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Eleos Inc. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eleos Inc. Recent Developments
11.7 ORCA Therapeutics B.V.
11.7.1 ORCA Therapeutics B.V. Corporation Information
11.7.2 ORCA Therapeutics B.V. Overview
11.7.3 ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ORCA Therapeutics B.V. Recent Developments
11.8 OSE Pharma SA
11.8.1 OSE Pharma SA Corporation Information
11.8.2 OSE Pharma SA Overview
11.8.3 OSE Pharma SA Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 OSE Pharma SA Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 OSE Pharma SA Recent Developments
11.9 PCI Biotech Holding ASA
11.9.1 PCI Biotech Holding ASA Corporation Information
11.9.2 PCI Biotech Holding ASA Overview
11.9.3 PCI Biotech Holding ASA Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 PCI Biotech Holding ASA Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PCI Biotech Holding ASA Recent Developments
11.10 Quark Pharmaceuticals, Inc.
11.10.1 Quark Pharmaceuticals, Inc. Corporation Information
11.10.2 Quark Pharmaceuticals, Inc. Overview
11.10.3 Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Quark Pharmaceuticals, Inc. Recent Developments
11.11 Stemline Therapeutics, Inc.
11.11.1 Stemline Therapeutics, Inc. Corporation Information
11.11.2 Stemline Therapeutics, Inc. Overview
11.11.3 Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Stemline Therapeutics, Inc. Recent Developments
11.12 Shenzen SiBiono GeneTech Co., Ltd.
11.12.1 Shenzen SiBiono GeneTech Co., Ltd. Corporation Information
11.12.2 Shenzen SiBiono GeneTech Co., Ltd. Overview
11.12.3 Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Shenzen SiBiono GeneTech Co., Ltd. Recent Developments
11.13 SK Biopharmaceuticals Co., Ltd.
11.13.1 SK Biopharmaceuticals Co., Ltd. Corporation Information
11.13.2 SK Biopharmaceuticals Co., Ltd. Overview
11.13.3 SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 SK Biopharmaceuticals Co., Ltd. Recent Developments
11.14 Tara Immuno-Oncology Therapeutics LLC
11.14.1 Tara Immuno-Oncology Therapeutics LLC Corporation Information
11.14.2 Tara Immuno-Oncology Therapeutics LLC Overview
11.14.3 Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Tara Immuno-Oncology Therapeutics LLC Recent Developments
11.15 Z53 Therapeutics, LLC
11.15.1 Z53 Therapeutics, LLC Corporation Information
11.15.2 Z53 Therapeutics, LLC Overview
11.15.3 Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Z53 Therapeutics, LLC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cellular Tumor Antigen p53 Industry Chain Analysis
12.2 Cellular Tumor Antigen p53 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cellular Tumor Antigen p53 Production Mode & Process
12.4 Cellular Tumor Antigen p53 Sales and Marketing
12.4.1 Cellular Tumor Antigen p53 Sales Channels
12.4.2 Cellular Tumor Antigen p53 Distributors
12.5 Cellular Tumor Antigen p53 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cellular Tumor Antigen p53 Industry Trends
13.2 Cellular Tumor Antigen p53 Market Drivers
13.3 Cellular Tumor Antigen p53 Market Challenges
13.4 Cellular Tumor Antigen p53 Market Restraints
14 Key Findings in The Global Cellular Tumor Antigen p53 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Cellular Tumor Antigen p53 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of COTI-2
Table 3. Major Manufacturers of D-12PGJ3
Table 4. Major Manufacturers of APR-246
Table 5. Major Manufacturers of ATRN-502
Table 6. Major Manufacturers of Cenersen Sodium
Table 7. Major Manufacturers of MJ-05
Table 8. Major Manufacturers of MX-225
Table 9. Major Manufacturers of Others
Table 10. Global Cellular Tumor Antigen p53 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Cellular Tumor Antigen p53 Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Cellular Tumor Antigen p53 Sales by Region (2017-2022) & (K Pcs)
Table 13. Global Cellular Tumor Antigen p53 Sales Market Share by Region (2017-2022)
Table 14. Global Cellular Tumor Antigen p53 Sales by Region (2023-2028) & (K Pcs)
Table 15. Global Cellular Tumor Antigen p53 Sales Market Share by Region (2023-2028)
Table 16. Global Cellular Tumor Antigen p53 Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Cellular Tumor Antigen p53 Revenue Market Share by Region (2017-2022)
Table 18. Global Cellular Tumor Antigen p53 Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Cellular Tumor Antigen p53 Revenue Market Share by Region (2023-2028)
Table 20. Global Cellular Tumor Antigen p53 Sales by Manufacturers (2017-2022) & (K Pcs)
Table 21. Global Cellular Tumor Antigen p53 Sales Share by Manufacturers (2017-2022)
Table 22. Global Cellular Tumor Antigen p53 Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Global Cellular Tumor Antigen p53 Revenue Share by Manufacturers (2017-2022)
Table 24. Cellular Tumor Antigen p53 Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 25. Global Cellular Tumor Antigen p53 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Cellular Tumor Antigen p53 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular Tumor Antigen p53 as of 2021)
Table 27. Cellular Tumor Antigen p53 Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Cellular Tumor Antigen p53 Product Offered
Table 29. Date of Manufacturers Enter into Cellular Tumor Antigen p53 Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Cellular Tumor Antigen p53 Sales by Type (2017-2022) & (K Pcs)
Table 32. Global Cellular Tumor Antigen p53 Sales by Type (2023-2028) & (K Pcs)
Table 33. Global Cellular Tumor Antigen p53 Sales Share by Type (2017-2022)
Table 34. Global Cellular Tumor Antigen p53 Sales Share by Type (2023-2028)
Table 35. Global Cellular Tumor Antigen p53 Revenue by Type (2017-2022) & (US$ Million)
Table 36. Global Cellular Tumor Antigen p53 Revenue by Type (2023-2028) & (US$ Million)
Table 37. Global Cellular Tumor Antigen p53 Revenue Share by Type (2017-2022)
Table 38. Global Cellular Tumor Antigen p53 Revenue Share by Type (2023-2028)
Table 39. Cellular Tumor Antigen p53 Price by Type (2017-2022) & (USD/Pcs)
Table 40. Global Cellular Tumor Antigen p53 Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 41. Global Cellular Tumor Antigen p53 Sales by Application (2017-2022) & (K Pcs)
Table 42. Global Cellular Tumor Antigen p53 Sales by Application (2023-2028) & (K Pcs)
Table 43. Global Cellular Tumor Antigen p53 Sales Share by Application (2017-2022)
Table 44. Global Cellular Tumor Antigen p53 Sales Share by Application (2023-2028)
Table 45. Global Cellular Tumor Antigen p53 Revenue by Application (2017-2022) & (US$ Million)
Table 46. Global Cellular Tumor Antigen p53 Revenue by Application (2023-2028) & (US$ Million)
Table 47. Global Cellular Tumor Antigen p53 Revenue Share by Application (2017-2022)
Table 48. Global Cellular Tumor Antigen p53 Revenue Share by Application (2023-2028)
Table 49. Cellular Tumor Antigen p53 Price by Application (2017-2022) & (USD/Pcs)
Table 50. Global Cellular Tumor Antigen p53 Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 51. North America Cellular Tumor Antigen p53 Sales by Type (2017-2022) & (K Pcs)
Table 52. North America Cellular Tumor Antigen p53 Sales by Type (2023-2028) & (K Pcs)
Table 53. North America Cellular Tumor Antigen p53 Revenue by Type (2017-2022) & (US$ Million)
Table 54. North America Cellular Tumor Antigen p53 Revenue by Type (2023-2028) & (US$ Million)
Table 55. North America Cellular Tumor Antigen p53 Sales by Application (2017-2022) & (K Pcs)
Table 56. North America Cellular Tumor Antigen p53 Sales by Application (2023-2028) & (K Pcs)
Table 57. North America Cellular Tumor Antigen p53 Revenue by Application (2017-2022) & (US$ Million)
Table 58. North America Cellular Tumor Antigen p53 Revenue by Application (2023-2028) & (US$ Million)
Table 59. North America Cellular Tumor Antigen p53 Sales by Country (2017-2022) & (K Pcs)
Table 60. North America Cellular Tumor Antigen p53 Sales by Country (2023-2028) & (K Pcs)
Table 61. North America Cellular Tumor Antigen p53 Revenue by Country (2017-2022) & (US$ Million)
Table 62. North America Cellular Tumor Antigen p53 Revenue by Country (2023-2028) & (US$ Million)
Table 63. Europe Cellular Tumor Antigen p53 Sales by Type (2017-2022) & (K Pcs)
Table 64. Europe Cellular Tumor Antigen p53 Sales by Type (2023-2028) & (K Pcs)
Table 65. Europe Cellular Tumor Antigen p53 Revenue by Type (2017-2022) & (US$ Million)
Table 66. Europe Cellular Tumor Antigen p53 Revenue by Type (2023-2028) & (US$ Million)
Table 67. Europe Cellular Tumor Antigen p53 Sales by Application (2017-2022) & (K Pcs)
Table 68. Europe Cellular Tumor Antigen p53 Sales by Application (2023-2028) & (K Pcs)
Table 69. Europe Cellular Tumor Antigen p53 Revenue by Application (2017-2022) & (US$ Million)
Table 70. Europe Cellular Tumor Antigen p53 Revenue by Application (2023-2028) & (US$ Million)
Table 71. Europe Cellular Tumor Antigen p53 Sales by Country (2017-2022) & (K Pcs)
Table 72. Europe Cellular Tumor Antigen p53 Sales by Country (2023-2028) & (K Pcs)
Table 73. Europe Cellular Tumor Antigen p53 Revenue by Country (2017-2022) & (US$ Million)
Table 74. Europe Cellular Tumor Antigen p53 Revenue by Country (2023-2028) & (US$ Million)
Table 75. Asia Pacific Cellular Tumor Antigen p53 Sales by Type (2017-2022) & (K Pcs)
Table 76. Asia Pacific Cellular Tumor Antigen p53 Sales by Type (2023-2028) & (K Pcs)
Table 77. Asia Pacific Cellular Tumor Antigen p53 Revenue by Type (2017-2022) & (US$ Million)
Table 78. Asia Pacific Cellular Tumor Antigen p53 Revenue by Type (2023-2028) & (US$ Million)
Table 79. Asia Pacific Cellular Tumor Antigen p53 Sales by Application (2017-2022) & (K Pcs)
Table 80. Asia Pacific Cellular Tumor Antigen p53 Sales by Application (2023-2028) & (K Pcs)
Table 81. Asia Pacific Cellular Tumor Antigen p53 Revenue by Application (2017-2022) & (US$ Million)
Table 82. Asia Pacific Cellular Tumor Antigen p53 Revenue by Application (2023-2028) & (US$ Million)
Table 83. Asia Pacific Cellular Tumor Antigen p53 Sales by Region (2017-2022) & (K Pcs)
Table 84. Asia Pacific Cellular Tumor Antigen p53 Sales by Region (2023-2028) & (K Pcs)
Table 85. Asia Pacific Cellular Tumor Antigen p53 Revenue by Region (2017-2022) & (US$ Million)
Table 86. Asia Pacific Cellular Tumor Antigen p53 Revenue by Region (2023-2028) & (US$ Million)
Table 87. Latin America Cellular Tumor Antigen p53 Sales by Type (2017-2022) & (K Pcs)
Table 88. Latin America Cellular Tumor Antigen p53 Sales by Type (2023-2028) & (K Pcs)
Table 89. Latin America Cellular Tumor Antigen p53 Revenue by Type (2017-2022) & (US$ Million)
Table 90. Latin America Cellular Tumor Antigen p53 Revenue by Type (2023-2028) & (US$ Million)
Table 91. Latin America Cellular Tumor Antigen p53 Sales by Application (2017-2022) & (K Pcs)
Table 92. Latin America Cellular Tumor Antigen p53 Sales by Application (2023-2028) & (K Pcs)
Table 93. Latin America Cellular Tumor Antigen p53 Revenue by Application (2017-2022) & (US$ Million)
Table 94. Latin America Cellular Tumor Antigen p53 Revenue by Application (2023-2028) & (US$ Million)
Table 95. Latin America Cellular Tumor Antigen p53 Sales by Country (2017-2022) & (K Pcs)
Table 96. Latin America Cellular Tumor Antigen p53 Sales by Country (2023-2028) & (K Pcs)
Table 97. Latin America Cellular Tumor Antigen p53 Revenue by Country (2017-2022) & (US$ Million)
Table 98. Latin America Cellular Tumor Antigen p53 Revenue by Country (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Cellular Tumor Antigen p53 Sales by Type (2017-2022) & (K Pcs)
Table 100. Middle East and Africa Cellular Tumor Antigen p53 Sales by Type (2023-2028) & (K Pcs)
Table 101. Middle East and Africa Cellular Tumor Antigen p53 Revenue by Type (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Cellular Tumor Antigen p53 Revenue by Type (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Cellular Tumor Antigen p53 Sales by Application (2017-2022) & (K Pcs)
Table 104. Middle East and Africa Cellular Tumor Antigen p53 Sales by Application (2023-2028) & (K Pcs)
Table 105. Middle East and Africa Cellular Tumor Antigen p53 Revenue by Application (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Cellular Tumor Antigen p53 Revenue by Application (2023-2028) & (US$ Million)
Table 107. Middle East and Africa Cellular Tumor Antigen p53 Sales by Country (2017-2022) & (K Pcs)
Table 108. Middle East and Africa Cellular Tumor Antigen p53 Sales by Country (2023-2028) & (K Pcs)
Table 109. Middle East and Africa Cellular Tumor Antigen p53 Revenue by Country (2017-2022) & (US$ Million)
Table 110. Middle East and Africa Cellular Tumor Antigen p53 Revenue by Country (2023-2028) & (US$ Million)
Table 111. Advaxis, Inc. Corporation Information
Table 112. Advaxis, Inc. Description and Major Businesses
Table 113. Advaxis, Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 114. Advaxis, Inc. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Advaxis, Inc. Recent Developments
Table 116. American Gene Technologies International Inc. Corporation Information
Table 117. American Gene Technologies International Inc. Description and Major Businesses
Table 118. American Gene Technologies International Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 119. American Gene Technologies International Inc. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. American Gene Technologies International Inc. Recent Developments
Table 121. Aprea AB Corporation Information
Table 122. Aprea AB Description and Major Businesses
Table 123. Aprea AB Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 124. Aprea AB Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Aprea AB Recent Developments
Table 126. Cellceutix Corporation Corporation Information
Table 127. Cellceutix Corporation Description and Major Businesses
Table 128. Cellceutix Corporation Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 129. Cellceutix Corporation Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Cellceutix Corporation Recent Developments
Table 131. Critical Outcome Technologies Inc. Corporation Information
Table 132. Critical Outcome Technologies Inc. Description and Major Businesses
Table 133. Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 134. Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Critical Outcome Technologies Inc. Recent Developments
Table 136. Eleos Inc. Corporation Information
Table 137. Eleos Inc. Description and Major Businesses
Table 138. Eleos Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 139. Eleos Inc. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Eleos Inc. Recent Developments
Table 141. ORCA Therapeutics B.V. Corporation Information
Table 142. ORCA Therapeutics B.V. Description and Major Businesses
Table 143. ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 144. ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. ORCA Therapeutics B.V. Recent Developments
Table 146. OSE Pharma SA Corporation Information
Table 147. OSE Pharma SA Description and Major Businesses
Table 148. OSE Pharma SA Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 149. OSE Pharma SA Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. OSE Pharma SA Recent Developments
Table 151. PCI Biotech Holding ASA Corporation Information
Table 152. PCI Biotech Holding ASA Description and Major Businesses
Table 153. PCI Biotech Holding ASA Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 154. PCI Biotech Holding ASA Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. PCI Biotech Holding ASA Recent Developments
Table 156. Quark Pharmaceuticals, Inc. Corporation Information
Table 157. Quark Pharmaceuticals, Inc. Description and Major Businesses
Table 158. Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 159. Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Quark Pharmaceuticals, Inc. Recent Developments
Table 161. Stemline Therapeutics, Inc. Corporation Information
Table 162. Stemline Therapeutics, Inc. Description and Major Businesses
Table 163. Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 164. Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Stemline Therapeutics, Inc. Recent Developments
Table 166. Shenzen SiBiono GeneTech Co., Ltd. Corporation Information
Table 167. Shenzen SiBiono GeneTech Co., Ltd. Description and Major Businesses
Table 168. Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 169. Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Shenzen SiBiono GeneTech Co., Ltd. Recent Developments
Table 171. SK Biopharmaceuticals Co., Ltd. Corporation Information
Table 172. SK Biopharmaceuticals Co., Ltd. Description and Major Businesses
Table 173. SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 174. SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. SK Biopharmaceuticals Co., Ltd. Recent Developments
Table 176. Tara Immuno-Oncology Therapeutics LLC Corporation Information
Table 177. Tara Immuno-Oncology Therapeutics LLC Description and Major Businesses
Table 178. Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 179. Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Tara Immuno-Oncology Therapeutics LLC Recent Developments
Table 181. Z53 Therapeutics, LLC Corporation Information
Table 182. Z53 Therapeutics, LLC Description and Major Businesses
Table 183. Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 184. Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Product Model Numbers, Pictures, Descriptions and Specifications
Table 185. Z53 Therapeutics, LLC Recent Developments
Table 186. Key Raw Materials Lists
Table 187. Raw Materials Key Suppliers Lists
Table 188. Cellular Tumor Antigen p53 Distributors List
Table 189. Cellular Tumor Antigen p53 Customers List
Table 190. Cellular Tumor Antigen p53 Market Trends
Table 191. Cellular Tumor Antigen p53 Market Drivers
Table 192. Cellular Tumor Antigen p53 Market Challenges
Table 193. Cellular Tumor Antigen p53 Market Restraints
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Cellular Tumor Antigen p53 Product Picture
Figure 3. Global Cellular Tumor Antigen p53 Market Share by Type in 2021 & 2028
Figure 3. COTI-2 Product Picture
Figure 4. D-12PGJ3 Product Picture
Figure 5. APR-246 Product Picture
Figure 6. ATRN-502 Product Picture
Figure 7. Cenersen Sodium Product Picture
Figure 8. MJ-05 Product Picture
Figure 9. MX-225 Product Picture
Figure 10. Others Product Picture
Figure 11. Global Cellular Tumor Antigen p53 Market Share by Application in 2021 & 2028
Figure 12. Ovarian Cancer
Figure 13. Prostate Cancer
Figure 14. Brain Cancer
Figure 15. Others
Figure 16. Cellular Tumor Antigen p53 Report Years Considered
Figure 17. Global Cellular Tumor Antigen p53 Sales 2017-2028 (K Pcs)
Figure 18. Global Cellular Tumor Antigen p53 Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Cellular Tumor Antigen p53 Revenue 2017-2028 (US$ Million)
Figure 20. Global Cellular Tumor Antigen p53 Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global Cellular Tumor Antigen p53 Sales Market Share by Region (2017-2022)
Figure 22. Global Cellular Tumor Antigen p53 Sales Market Share by Region (2023-2028)
Figure 23. North America Cellular Tumor Antigen p53 Sales YoY (2017-2028) & (K Pcs)
Figure 24. North America Cellular Tumor Antigen p53 Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe Cellular Tumor Antigen p53 Sales YoY (2017-2028) & (K Pcs)
Figure 26. Europe Cellular Tumor Antigen p53 Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Cellular Tumor Antigen p53 Sales YoY (2017-2028) & (K Pcs)
Figure 28. Asia-Pacific Cellular Tumor Antigen p53 Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America Cellular Tumor Antigen p53 Sales YoY (2017-2028) & (K Pcs)
Figure 30. Latin America Cellular Tumor Antigen p53 Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa Cellular Tumor Antigen p53 Sales YoY (2017-2028) & (K Pcs)
Figure 32. Middle East & Africa Cellular Tumor Antigen p53 Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The Cellular Tumor Antigen p53 Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of Cellular Tumor Antigen p53 in the World: Market Share by Cellular Tumor Antigen p53 Revenue in 2021
Figure 35. Global Cellular Tumor Antigen p53 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global Cellular Tumor Antigen p53 Sales Market Share by Type (2017-2028)
Figure 37. Global Cellular Tumor Antigen p53 Revenue Market Share by Type (2017-2028)
Figure 38. Global Cellular Tumor Antigen p53 Sales Market Share by Application (2017-2028)
Figure 39. Global Cellular Tumor Antigen p53 Revenue Market Share by Application (2017-2028)
Figure 40. North America Cellular Tumor Antigen p53 Sales Market Share by Type (2017-2028)
Figure 41. North America Cellular Tumor Antigen p53 Revenue Market Share by Type (2017-2028)
Figure 42. North America Cellular Tumor Antigen p53 Sales Market Share by Application (2017-2028)
Figure 43. North America Cellular Tumor Antigen p53 Revenue Market Share by Application (2017-2028)
Figure 44. North America Cellular Tumor Antigen p53 Sales Share by Country (2017-2028)
Figure 45. North America Cellular Tumor Antigen p53 Revenue Share by Country (2017-2028)
Figure 46. U.S. Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 47. Canada Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 48. Europe Cellular Tumor Antigen p53 Sales Market Share by Type (2017-2028)
Figure 49. Europe Cellular Tumor Antigen p53 Revenue Market Share by Type (2017-2028)
Figure 50. Europe Cellular Tumor Antigen p53 Sales Market Share by Application (2017-2028)
Figure 51. Europe Cellular Tumor Antigen p53 Revenue Market Share by Application (2017-2028)
Figure 52. Europe Cellular Tumor Antigen p53 Sales Share by Country (2017-2028)
Figure 53. Europe Cellular Tumor Antigen p53 Revenue Share by Country (2017-2028)
Figure 54. Germany Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 55. France Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 57. Italy Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 58. Russia Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific Cellular Tumor Antigen p53 Sales Market Share by Type (2017-2028)
Figure 60. Asia Pacific Cellular Tumor Antigen p53 Revenue Market Share by Type (2017-2028)
Figure 61. Asia Pacific Cellular Tumor Antigen p53 Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific Cellular Tumor Antigen p53 Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific Cellular Tumor Antigen p53 Sales Share by Region (2017-2028)
Figure 64. Asia Pacific Cellular Tumor Antigen p53 Revenue Share by Region (2017-2028)
Figure 65. China Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 66. Japan Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 68. India Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 69. Australia Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 70. Taiwan Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 74. Philippines Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 75. Latin America Cellular Tumor Antigen p53 Sales Market Share by Type (2017-2028)
Figure 76. Latin America Cellular Tumor Antigen p53 Revenue Market Share by Type (2017-2028)
Figure 77. Latin America Cellular Tumor Antigen p53 Sales Market Share by Application (2017-2028)
Figure 78. Latin America Cellular Tumor Antigen p53 Revenue Market Share by Application (2017-2028)
Figure 79. Latin America Cellular Tumor Antigen p53 Sales Share by Country (2017-2028)
Figure 80. Latin America Cellular Tumor Antigen p53 Revenue Share by Country (2017-2028)
Figure 81. Mexico Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 82. Brazil Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 83. Argentina Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 84. Middle East and Africa Cellular Tumor Antigen p53 Sales Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Cellular Tumor Antigen p53 Revenue Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Cellular Tumor Antigen p53 Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Cellular Tumor Antigen p53 Revenue Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Cellular Tumor Antigen p53 Sales Share by Country (2017-2028)
Figure 89. Middle East and Africa Cellular Tumor Antigen p53 Revenue Share by Country (2017-2028)
Figure 90. Turkey Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 91. Saudi Arabia Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 92. U.A.E Cellular Tumor Antigen p53 Revenue (2017-2028) & (US$ Million)
Figure 93. Cellular Tumor Antigen p53 Value Chain
Figure 94. Cellular Tumor Antigen p53 Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
Industry Market Size
